ストックスクリーナーアプリを入手
2.03
0.00%
0.00
Omniab Inc (OABI) 最新ニュース
Enterprise value to EBIT forward of OmniAb, Inc. – NASDAQ:OABI - TradingView
Veraxa Biotech (VRXA) moves bispecific ADC VXA-222 program forward - Stock Titan
VERAXA Biotech (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration - Benzinga
Veraxa Advances Bispecific ADC Candidate VXA-222 Following OmniAb Discovery Milestone - BioPharm International
Veraxa Biotech advances bispecific ADC from Omniab collaboration - BioWorld News
OABI|OmniAb Inc|Price:2.000|Chg%:-0.030 - TradingKey
Veraxa advances cancer therapy program with OmniAb - Investing.com
VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb - The Manila Times
VERAXA Biotech Announces Advancement of VXA-222 Bispecific ADC Program in Collaboration with OmniAb - Quiver Quantitative
Veraxa advances cancer therapy program with OmniAb By Investing.com - Investing.com Canada
VERAXA’s VXA-222 Uses One Molecule to Address Two Tumor Antigens - Stock Titan
OmniAb Inc (OABI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OmniAb Inc (OABI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TradingKey - TradingKey
OmniAb Inc (OABI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OmniAb Market Sentiment - Benzinga
Price to sales forward of OmniAb, Inc. – NASDAQ:OABI - TradingView
OmniAb Inc (OABI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OmniAb (OABI) Holds Near Support Amid Modest DeclineFear Greed Extreme - dars.gov.et
OmniAb spotlights OmniUltra platform for radioligand therapy at San Diego summit - Traders Union
OmniAb Inc (OABI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OABI|OmniAb Inc|Price:2.030|Chg%:-0.010 - TradingKey
OmniAb to present in vivo discovery technology for radioligand therapy at San Diego summit - Traders Union
Enterprise value to EBITDA forward of OmniAb, Inc. – NASDAQ:OABI - TradingView
OmniAb Q1 2026 Earnings: EPS Surprises Positively Despite Pre-Revenue StageAnalyst Earnings Estimate - dars.gov.et
OmniAb to Report Second Quarter 2026 Financial Results on August 6 - BioSpace
OmniAb stock rises after naming new chief operating officer - Investing.com
OmniAb Appoints Amechi Nwachuku as Chief Operating Officer Effective July 13, 2026 - geneonline.com
OmniAb, Inc. Appoints Amechi Nwachuku as Chief Operating Officer – Leadership Update July 2026 - Minichart
OmniAb appoints Amechi Nwachuku as chief operating officer - Investing.com UK
OMEGA relocates headquarters from Cambridge to New Philadelphia - AOL.com
Omniab, Inc. Appoints Amechi Nwachuku as Executive Vice President and Chief Operating Officer, Effective July 13, 2026 - marketscreener.com
OmniAb Taps Amechi Nwachuku as Executive Vice President & Chief Operating Officer - Contract Pharma
OmniAb stock rises after naming new chief operating officer By Investing.com - Investing.com Nigeria
OmniAb Appoints Amechi Nwachuku COO to Expand xPloration Platform Commercialization - citybiz
OmniAb Appoints Amechi Nwachuku as Chief Operating Officer - Moomoo
OmniAb appoints Amechi Nwachuku as chief operating officer By Investing.com - Investing.com South Africa
OmniAb Names Amechi Nwachuku Chief Operating Officer - TipRanks
Amechi Nwachuku named COO at OmniAb with stock options and severance - TradingView
OmniAb (NASDAQ: OABI) hires COO with $445K salary, 800K options - Stock Titan
OmniAb Inc. (OABI) Climbs 2.23% as Shares Approach Key Resistance at $2.40Strangle Setup - dars.gov.et
OmniAb (OABI) Edges Lower Amid Quiet Trading – Support Levels in FocusLow Volume Node - dars.gov.et
OABI,VKTX Revenue Breakdown - Finviz
VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines - GlobeNewswire Inc.
OmniAb Inc. (OABI) Edges Higher, Testing Key Resistance ZoneMomentum Breakout Ideas - dars.gov.et
OmniAb (OABI) Price Target Decreased by 13.73% to 7.48 - MSN
OABIOmniAb Inc Volatility & Greeks - Finviz
OmniAb (OABI) Gains More Than 38% Over 6 Months, Can It Go Higher? - Yahoo Finance
OmniAb, Inc. Warrant 2022- on Omniab Inc Financial Disclosures & SEC Filings - TradingView
OmniAb, Inc. Financial Disclosures & SEC Filings - TradingView
OmniAb (NASDAQ:OABI) Cash Burn Looks Manageable - Kalkine Media
OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Earnings Preview: OmniAb to Report Financial Results Post-market on May 07 - Moomoo
OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 2000 Growth Benchmark - marketscreener.com
1.97%
0.83%
大文字化:
|
ボリューム (24 時間):